Cosmetics Product Launch Checklist: A Workflow From Formula to Shelf

A cosmetics product launch checklist works best as a workflow, not a list. Lock the formula and its INCI list as the master record, complete the safety assessment, approve labels against that record, file the notifications each market requires, review every claim, then prepare artwork and listings. Automation tracks and compares; qualified people sign off.

Most beauty brands have a launch checklist in a spreadsheet one person updates, while the real work happens across email threads with the manufacturer, safety assessor, designer and retailers. This guide turns it into a staged workflow with triggers, owners and review points.

It is a practical overview, not legal advice. Cosmetics rules differ by market, so check the rules where you sell and work with a qualified safety assessor and regulatory adviser.

Why cosmetics launches slip

A launch has dependencies that only show up when they break:

• The formula changes late. A preservative swap means a new ingredient list, new artwork, an updated safety assessment and changed notifications. If nobody links those tasks, one gets missed.
• Ingredient data drifts. The INCI list on the label, website, retailer template and regulatory file should match. After a revision, one is usually left behind.
• Claims arrive from everywhere. Product copy, retailer descriptions and creator briefs all add wording, and some can push a cosmetic towards being treated as a drug.
• Markets have different clocks. Some notifications are due before sale, some after.

The fix is one master record, visible dependencies and checks at the right moments.

The cosmetics product launch checklist as a workflow

Each stage has a trigger, what can be automated and who reviews. A document arriving or a decision being logged moves the launch forward; the decisions stay with people.

1. Formula lock and master record

Trigger: the brand approves the final lab sample.

The approved formula, INCI list, specifications and supplier documents become the master record. Automation creates the launch project from a template, links every downstream task to this record and notifies owners. If the INCI list is later edited, dependent tasks are flagged for recheck.

Who reviews: the product development or regulatory lead confirms the master record.

2. Testing and safety assessment

Trigger: the master record is locked.

Stability, compatibility and preservative efficacy reports arrive from labs. Automation can file each one against the product, update the task and chase anything overdue, then gather the reports into one pack for the safety assessor. Small brands can assemble that pack with a free PDF merge tool.

What the safety assessment must contain depends on the market. In the EU, Regulation (EC) No 1223/2009 requires a cosmetic product safety report by a qualified assessor and a product information file kept for ten years after the last batch is placed on the market. Great Britain keeps an equivalent regime under the UK Cosmetics Regulation. In the US, MoCRA requires the responsible person to ensure and keep records supporting product safety, without prescribing specific tests.

Who reviews: the qualified safety assessor and the regulatory lead. Automation never judges whether evidence is sufficient.

3. Labelling and artwork

Trigger: the safety assessment is signed off and the master INCI list is confirmed.

Label copy is drafted from the master record: ingredients, net quantity, warnings, batch and responsible person details. When a proof arrives, compare its ingredient text with the master list. Paste both into the diff checker and differences in order, spelling or missing allergens stand out.

Labelling rules vary. Australia's ACCC enforces a mandatory standard for cosmetics ingredient labelling that applies to online stores too, and Canada and the EU have their own requirements.

Who reviews: the regulatory lead approves label content; the brand director approves design.

4. Regulatory notifications per market

Trigger: final labels are approved.

Here a tracker earns its keep. Automation can hold a task per market, count back from the launch date (a working days calculator helps when planning by hand), remind the responsible person before each deadline and prepare the data they need from the master record.

A few details matter. FDA says certain small businesses are exempt from registration and listing, but not for products such as those used around the eye, injected, intended for internal use or meant to alter appearance for more than 24 hours. Northern Ireland uses the EU portal rather than SCPN. In Australia, AICIS registers the business rather than each product, and some sunscreens are regulated as therapeutic goods by the TGA rather than as cosmetics.

Who reviews: the responsible person in each market submits and signs off. The system only tracks status.

5. Claims review

Trigger: product copy, retailer descriptions or creator briefs are drafted.

Every claim is checked against an approved claims list linked to the evidence behind it. Automation can highlight wording that is not on that list, or that sounds therapeutic, such as "heals", "treats eczema" or "regrows hair", and send the draft to the right reviewer.

Claims change how a product is regulated. FDA decides whether a product is a cosmetic or a drug by intended use, including the claims made for it. In the EU and Great Britain, cosmetic claims must meet common criteria including truthfulness, evidential support and honesty. Our guide to cosmetics advertising rules for brand websites goes deeper on claims and images for the UK.

Who reviews: the regulatory lead decides on every new or borderline claim. Automation flags; people approve.

6. Listing assets and retailer data

Trigger: claims and labels are approved.

Product pages and retailer templates are built from the master record and approved copy. Automation can fill template fields that clearly match, highlight judgement fields, and prepare packshots for each channel with tools like our free image resizer and image compressor. Our product image size guide lists common dimensions. Before publishing, compare listing ingredients with the master list once more.

Who reviews: the e-commerce and account managers check every listing and template before it goes out.

7. Launch readiness and the first weeks

Trigger: all market tasks show complete.

A readiness summary goes to the brand director with each market's status and open items. After launch, messages and reviews that may describe a reaction go straight to the safety contact, with product and batch details where available. Under MoCRA, serious adverse events must be reported to FDA within 15 business days, and the EU and UK have their own reporting duties for serious undesirable effects.

Who reviews: the brand director and regulatory lead decide whether the product launches in each market. Safety reports are always handled by people.

Summary: who does what at each stage

What stays human

Automation keeps information moving. Decisions with legal and safety weight stay with qualified people:

• Safety assessment and substantiation.
• Approving claims and deciding whether a product is a cosmetic or a drug.
• Handling and reporting adverse reactions.
• Launch readiness and notification sign-off in each market.
• Recalls and formulation changes.

Our page on automation for beauty brands describes the wider picture.

Data protection and legal checks

A launch workflow also touches personal data: supplier contacts, creator details and, after launch, customers describing skin reactions, which can be health information.

• EU and UK: health data is special category data under the GDPR and UK GDPR. The ICO's guidance explains the extra conditions that apply.
• US: there is no single federal privacy law for this, but some states have their own. Washington's My Health My Data Act covers consumer health data and allows private lawsuits.
• Canada and Australia: federal privacy laws, PIPEDA and the Privacy Act, apply to many businesses, with health information treated as sensitive.

For every automated step, know which services see the data, sign their processing terms and limit access. Check the rules where you operate.

How to start small and measure

You do not need a full platform on day one. A sensible first version:

1. Pick your next launch and one task tool your team already uses.
2. Write the master record: formula reference, INCI list, claims list and label requirements per market.
3. Build the launch template from the seven stages above, with dependencies on the master record.
4. Add two automations: reminders before each due date, and a flag when the master INCI list changes.
5. Compare every label proof and listing with the master list before approval.

Measure it qualitatively. After launch, ask where the team still chased people and whether any ingredient version slipped through. Fix those, then add the next automation. Make It Flow starts the same way: mapping how a launch moves through your brand, then automating what repeats. If you would like help, talk to us.

FAQ

What should a cosmetics product launch checklist include?

At minimum: a locked formula and INCI list, test reports, a signed safety assessment, approved labels for each market, regulatory notifications or listings, reviewed claims, artwork, product listings and retailer data, and a launch readiness sign-off. After launch, add a process for routing reaction reports to a named safety contact. The exact items depend on the markets you sell in.

Do I need to notify my product before selling it?

It depends on the market. The EU and Great Britain require notification before the product is placed on the market, through the CPNP and SCPN respectively. In the US, MoCRA product listing is due within 120 days of first marketing. Canada expects a Cosmetic Notification Form within 10 days after first sale. Check current rules for every market you sell in.

Can automation complete regulatory notifications for us?

It can prepare the information those submissions rely on, such as product names, categories, ingredient lists and label images, and remind the responsible person before each deadline. The submission itself, and confirming that the information is accurate, stays with the responsible person in each market. That keeps accountability where the law places it.

How do we keep ingredient lists consistent across labels and listings?

Treat the approved INCI list in your regulatory record as the master version. Compare every label proof, website listing and retailer template with it before approval, using a text comparison tool or an automated check. When the formula changes, flag every dependent item for review so nothing is left showing an old list.

Who should review cosmetic claims?

Your regulatory lead or an external regulatory adviser should approve every new or borderline claim, supported by evidence. Automation can flag wording that is not on your approved claims list or that sounds therapeutic, but it cannot judge whether evidence is adequate or whether a claim makes the product a drug in a particular market.

How long before launch should we start the workflow?

Start as soon as the formula is close to final, because testing, safety assessment, artwork and notifications depend on it. Some steps have fixed lead times, such as the six-month advance notice generally needed for nanomaterials in the EU and Great Britain. Map each market's deadlines backwards from your launch date and build in time for revisions.